A carregar...
Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases
While de-escalation of bisphosphonates from 4 to 12-weekly dosing has been shown to be clinically non-inferior to standard dosing, there is evidence the de-escalation is associated with increased bone turnover biomarkers. Here we evaluated the effect of de-escalated dosing on a panel of biomarkers a...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4194305/ https://ncbi.nlm.nih.gov/pubmed/25332877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-3-577 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|